CStone Pharmaceuticals (CSPHF) Financials

CSPHF Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 302.6 million 112.4 million
Dec. 31, 2025 194.3 million 106.0 million
June 30, 2025 166.4 million 122.4 million
March 31, 2025 164.1 million 120.7 million

CSPHF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 ? 2.0 million
Dec. 31, 2025 -8.0 million ?
June 30, 2025 -5.3 million -212866
March 31, 2025 ? -104979

CSPHF Net Income

No data available :(

CSPHF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 229.6 million 27.9 million 2.4 million
Dec. 31, 2025 131.4 million 22.4 million 874337
June 30, 2025 91.1 million 23.6 million 3.9 million
March 31, 2025 95.0 million - -

CSPHF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 223.9 million
Dec. 31, 2025 218.4 million
June 30, 2025 183.4 million
March 31, 2025 180.9 million

CSPHF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 29.8 million 17.7 million -
Dec. 31, 2025 - 29.0 million 12.7 million -
June 30, 2025 - 7.3 million 5.5 million 2.5 million
March 31, 2025 - 7.2 million 3.0 million 2.5 million

CSPHF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 29.8 million 16.5 million
Dec. 31, 2025 30.9 million 11.1 million
June 30, 2025 3.5 million 9.9 million
March 31, 2025 3.4 million 9.8 million

CSPHF

Price: $0.76

52 week price:
0.59
1.01

Earnings Per Share: -0.04 USD

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 1.2 billion

Links: